VIA

Virtus Investment Advisers Portfolio holdings

AUM $368M
1-Year Est. Return 26.25%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+26.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$368M
AUM Growth
+$18.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
553
New
Increased
Reduced
Closed

Top Buys

1 +$2.17M
2 +$2.09M
3 +$2.03M
4
AMAT icon
Applied Materials
AMAT
+$2.01M
5
LVS icon
Las Vegas Sands
LVS
+$2.01M

Top Sells

1 +$2.5M
2 +$2.43M
3 +$2.05M
4
MS icon
Morgan Stanley
MS
+$2.04M
5
ATO icon
Atmos Energy
ATO
+$2.02M

Sector Composition

1 Healthcare 26.73%
2 Financials 22.73%
3 Technology 18.16%
4 Industrials 8.89%
5 Consumer Discretionary 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KROS icon
326
Keros Therapeutics
KROS
$430M
$252K 0.07%
12,367
+4,025
ABCL icon
327
AbCellera Biologics
ABCL
$1.09B
$251K 0.07%
73,488
+37,365
RXRX icon
328
Recursion Pharmaceuticals
RXRX
$1.9B
$251K 0.07%
61,439
+39,430
CNTA
329
Centessa Pharmaceuticals
CNTA
$3.95B
$251K 0.07%
10,034
+583
ARVN icon
330
Arvinas
ARVN
$852M
$251K 0.07%
21,148
+6,117
ASMB icon
331
Assembly Biosciences
ASMB
$472M
$251K 0.07%
+7,369
NAMS icon
332
NewAmsterdam Pharma
NAMS
$3.79B
$251K 0.07%
7,142
+1,731
IRWD icon
333
Ironwood Pharmaceuticals
IRWD
$582M
$250K 0.07%
+74,311
SRRK icon
334
Scholar Rock
SRRK
$4.42B
$250K 0.07%
5,676
+2,261
XNCR icon
335
Xencor
XNCR
$870M
$247K 0.07%
16,103
+4,037
AMLX icon
336
Amylyx Pharmaceuticals
AMLX
$1.68B
$245K 0.07%
+20,307
PRTA icon
337
Prothena Corp
PRTA
$511M
$245K 0.07%
25,679
+3,236
RAPT icon
338
RAPT Therapeutics
RAPT
$1.68B
$245K 0.07%
+7,229
CRVS icon
339
Corvus Pharmaceuticals
CRVS
$1.49B
$245K 0.07%
31,783
+4,946
DNLI icon
340
Denali Therapeutics
DNLI
$3.32B
$244K 0.07%
14,795
+7,171
PTGX icon
341
Protagonist Therapeutics
PTGX
$5.86B
$244K 0.07%
2,790
+770
ELVN icon
342
Enliven Therapeutics
ELVN
$1.72B
$243K 0.07%
15,778
+9,991
BCAX
343
Bicara Therapeutics
BCAX
$946M
$242K 0.07%
14,395
+4,560
ALLO icon
344
Allogene Therapeutics
ALLO
$605M
$241K 0.07%
176,178
+94,902
ACLX icon
345
Arcellx
ACLX
$6.59B
$241K 0.07%
3,701
+1,990
JANX icon
346
Janux Therapeutics
JANX
$814M
$240K 0.07%
17,388
+12,936
VIR icon
347
Vir Biotechnology
VIR
$1.33B
$240K 0.07%
39,764
+17,966
TERN icon
348
Terns Pharmaceuticals
TERN
$4.56B
$239K 0.06%
5,912
-23,041
ZBIO
349
Zenas BioPharma
ZBIO
$1.36B
$238K 0.06%
+6,554
MGTX icon
350
MeiraGTx Holdings
MGTX
$609M
$237K 0.06%
+29,824